Cangene (FRA:YGE) Beginning Cash Position : €34.02 Mil (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Beginning Cash Position?

Cangene's Beginning Cash Position for the quarter that ended in Oct. 2013 was €34.02 Mil.

Cangene's quarterly Beginning Cash Position declined from Apr. 2013 (€29.73 Mil) to Jul. 2013 (€29.46 Mil) but then increased from Jul. 2013 (€29.46 Mil) to Oct. 2013 (€34.02 Mil).

Cangene's annual Beginning Cash Position increased from Jul. 2011 (€28.30 Mil) to Jul. 2012 (€36.77 Mil) but then declined from Jul. 2012 (€36.77 Mil) to Jul. 2013 (€27.40 Mil).

Cangene Beginning Cash Position Historical Data

The historical data trend for Cangene's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Beginning Cash Position Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Beginning Cash Position

Get a 7-Day Free Trial

11.07

40.66

28.30

36.77

27.40

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Beginning Cash Position	Get a 7-Day Free Trial															27.66	27.22	29.73	29.46	34.02

Cangene Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Cangene Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Cangene's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines